Acthar

Humana sues drugmaker Mallinckrodt over alleged price gouging

Humana alleges that Mallinckrodt illegally jacked up the price of the injected drug Acthar, causing the insurance company to pay several times more for the drug - which the FDA approved in 1952 - than it otherwise would have.

By Alaric DeArment

Pharma, Payers

Study highlights role of doctor conflicts of interest in Medicare spending on Mallinckrodt drug Acthar

Study published in JAMA indicates nearly 90 percent of doctors prescribing HP Acthar Gel took payments from drug's manufacturer.

By Alaric DeArment

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.